Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Endotoxin Control Strategies for Parenteral Drug Product Manufacturing
Robert Simler Associate Director, Engineering and Technology Biogen, Cambridge, MA, USA
Overcoming Obstacles in AAV Viral Vector Manufacturing
Characterization and Engineering Performance of the Allegro™ STR 500 Single-Use Stirred Tank Bioreactor
Bristol Myers Squibb adopts positive CHMP opinion for Opdivo plus Yervoy for patients with Microsatellite instability high or mismatch repair deficient metastatic colorectal cancer
Bristol Myers Squibb
View All Featured ArticlesHeadline News
FDA grants Priority Review to uniQure’s Huntington’s disease gene therapy
Impella registry analyses report lower mortality than CHIP-BCIS3 in high-risk PCI
Shockwave Javelin IVL catheter shows positive results in pivotal FORWARD CAD study
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Single Use Systems in Biologics Manufacturing and their Impact on Operational Technology
Presented by Gloria Gadea-Lopez, PhD, John Maguire & Mark Maselli of Shire followed by Ken Clapp of GE Healthcare
04th April 2017
Developability Assessment of Therapeutic Proteins – A Toolbox for Tackling Increasing Complexity
Presented by Thorsten Lorenz, Team Head Developability Assessment Biologics at Novartis and Beate Kern, Product Manager at NanoTemper Technologies
27th September 2018
Managing Biologics Process Analytical Technology in Pfizer
Presented by Keith Davis, Principle Scientist at Pfizer
12th March 2019
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Lifetime study for JSR Amsphere A3 – protein A resin
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
